| Bioactive natural compounds against human coronaviruses: a review and perspective Y Xian, J Zhang, Z Bian, H Zhou, Z Zhang, Z Lin, H Xu Acta Pharmaceutica Sinica B 10 (7), 1163-1174, 2020 | 190 | 2020 |
| The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2 J Zhang, Z Zheng, M Wu, L Zhang, J Wang, W Fu, N Xu, Z Zhao, Y Lao, ... Cell Death & Disease 10 (8), 554, 2019 | 40 | 2019 |
| SRC and MEK co-inhibition synergistically enhances the anti-tumor effect in both non-small-cell lung cancer (NSCLC) and erlotinib-resistant NSCLC M Yuan, L Xu, J Zhang, S Kong, M Wu, Y Lao, H Zhou, L Zhang, H Xu Frontiers in Oncology 9, 586, 2019 | 27 | 2019 |
| Natural Nrf2 inhibitors: a review of their potential for cancer treatment J Zhang, HX Xu, JQ Zhu, YX Dou, YF Xian, ZX Lin International Journal of Biological Sciences 19 (10), 3029, 2023 | 18 | 2023 |
| Major Constituents From Brucea javanica and Their Pharmacological Actions J Zhang, HX Xu, YX Dou, QH Huang, YF Xian, ZX Lin Frontiers in Pharmacology 13, 853119, 2022 | 18 | 2022 |
| Spirocyclic polycyclic polyprenylated acylphloroglucinols from the ethyl acetate fraction of Hypericum henryi YT Duan, J Zhang, YZ Lao, HS Tan, YS Ye, XW Yang, HX Xu, G Xu Tetrahedron Letters 59 (46), 4067-4072, 2018 | 17 | 2018 |
| The natural compound neobractatin induces cell cycle arrest by regulating E2F1 and Gadd45α Z Zheng, M Wu, J Zhang, W Fu, N Xu, Y Lao, L Lin, H Xu Frontiers in Oncology 9, 654, 2019 | 14 | 2019 |
| Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway J Zhang, HX Xu, WCS Cho, W Cheuk, Y Li, QH Huang, W Yang, YF Xian, ... Journal of Experimental & Clinical Cancer Research 41 (1), 90, 2022 | 11 | 2022 |
| Autophagy regulators in cancer J Zhang, Q Xiang, M Wu, YZ Lao, YF Xian, HX Xu, ZX Lin International Journal of Molecular Sciences 24 (13), 10944, 2023 | 10 | 2023 |
| Dendrobium nobile Lindl: A review on its chemical constituents and pharmacological effects J Zhang, HX Xu, ZL Zhao, YF Xian, ZX Lin Chinese Medicine and Culture 4 (4), 235-242, 2021 | 10 | 2021 |
| Dearomatized Isoprenylated Acylphloroglucinol Derivatives with Potential Antitumor Activities from Hypericum henryi YS Ye, M Wu, NN Jiang, YZ Lao, WW Fu, X Liu, XW Yang, J Zhang, HX Xu, ... Natural Products and Bioprospecting 10, 1-11, 2020 | 9 | 2020 |
| Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K/YAP1/TAZ Pathway QH Huang, J Zhang, WCS Cho, Y Huang, W Yang, Z Zuo, YF Xian, ZX Lin Phytomedicine 109, 154567, 2023 | 7 | 2023 |
| The Natural Compound Oblongifolin C Exhibits Anticancer Activity by Inhibiting HSPA8 and Cathepsin B In Vitro L Han, D Xu, Z Xi, M Wu, WN Nik Nabil, J Zhang, H Sui, W Fu, H Zhou, ... Frontiers in pharmacology 11, 564833, 2020 | 7 | 2020 |
| The natural compound neobractatin inhibits cell proliferation mainly by regulating the RNA binding protein CELF6 ZQ Zheng, JQ Tan, J Zhang, M Wu, G Chen, Z Li, XQ Shi, WW Fu, H Zhou, ... Food & Function 13 (4), 1741-1750, 2022 | 5 | 2022 |
| Synergistic Anti‐Tumor Effect of Toosendanin and Paclitaxel on Triple‐Negative Breast Cancer via Regulating ADORA2A‐EMT Related Signaling J Zhang, HX Xu, YL Wu, WCS Cho, YF Xian, ZX Lin Advanced Biology 7 (8), 2300062, 2023 | 2 | 2023 |
| Overview of research trends in precious chinese medicines HX Xu, ZX Lin Chinese Medicine and Culture 4 (4), 197-200, 2021 | 1 | 2021 |
| Chinese Medicine against the COVID-19: Current Status, Challenge and Perspectives ZL Zhang J, Wen Yang, Hong-Xi Xu, Lisa Xian Longhua Chinese Medicine 4, 36, 2021 | | 2021 |
